Startup, Biotech, Entrepreneurship, Startup Funding, Fundraising For Startups.
existing nucleoside analogue drugs, allowing more patients to be treated, and cost-effective repurposing of existing NA drugs for the treatment of MDR bacterial infections. “So, regarding our strategy, our idea is to complete over a pre-clinical phase and start the clinical trial one in the next